Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Consumer Staples | 11.26% |
| 5 | Industrials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Telkom Indonesia
TLK
$14.6B
| $3.58M | 0.01% |
199,600
+104,000
| +109% | +$1.97M |
|
1402
Bio-Rad Laboratories Class A
BIO
$9.59B
| $3.57M | 0.01% |
28,900
-42,800
| -60% | -$5.22M |
|
1403
Matthews International
MATW
$725M
| $3.57M | 0.01% |
83,804
+66,000
| +371% | +$2.69M |
|
1404
Stride
LRN
$3.46B
| $3.57M | 0.01% |
164,100
-117,800
| -42% | -$2.46M |
|
|
SDRL
1405
DELISTED
Seadrill Limited Common Stock
SDRL
| $3.56M | 0.01% |
324
-3,097
| -91% | -$36.5M |
|
1406
Stepan Co
SCL
$1.48B
| $3.53M | 0.01% |
53,800
+4,200
| +8% | +$256K |
|
|
PSEM
1407
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
| $3.52M | 0.01% |
397,523
-10,300
| -3% | -$87.5K |
|
1408
Pixelworks
PXLW
$44.5M
| $3.52M | 0.01% |
60,875
-15,958
| -21% | -$850K |
|
1409
Artivion
AORT
$1.41B
| $3.52M | 0.01% |
317,400
+107,900
| +52% | +$1.02M |
|
|
PRO
1410
DELISTED
PROS Holdings
PRO
| $3.52M | 0.01% |
88,200
+12,200
| +16% | +$438K |
|
1411
Acacia Research
ACTG
$447M
| $3.52M | 0.01% |
+241,900
| New | +$3.82M |
|
|
BEAV
1412
DELISTED
B/E Aerospace Inc
BEAV
| $3.52M | 0.01% |
55,801
-14,086
| -20% | -$841K |
|
|
JOYY
1413
JOYY Inc
JOYY
$3.68B
| $3.52M | 0.01% |
+69,900
| New | +$3.48M |
|
1414
Sun Communities
SUI
$15B
| $3.51M | 0.01% |
82,400
+68,700
| +501% | +$2.92M |
|
|
RNDY
1415
DELISTED
ROUNDYS INC COM STK
RNDY
| $3.51M | 0.01% |
355,700
+38,600
| +12% | +$349K |
|
1416
Molson Coors Class B
TAP
$7.92B
| $3.5M | 0.01% |
62,300
-801,300
| -93% | -$42.8M |
|
1417
CenterPoint Energy
CNP
$26.9B
| $3.49M | 0.01% |
150,700
-420,900
| -74% | -$10.1M |
|
1418
Unitil
UTL
$991M
| $3.49M | 0.01% |
114,400
+17,068
| +18% | +$514K |
|
|
FIO
1419
DELISTED
FUSION-IO INC COM
FIO
| $3.48M | 0.01% |
+390,814
| New | +$4.22M |
|
1420
Descartes Systems
DSGX
$6.6B
| $3.48M | 0.01% |
260,000
-32,500
| -11% | -$410K |
|
1421
C&F Financial
CFFI
$287M
| $3.48M | 0.01% |
76,090
+13,219
| +21% | +$668K |
|
|
MN
1422
DELISTED
MANNING & NAPIER, INC.
MN
| $3.46M | 0.01% |
196,200
+3,200
| +2% | +$55.4K |
|
1423
Regional Management Corp
RM
$307M
| $3.46M | 0.01% |
102,000
+59,500
| +140% | +$1.94M |
|
1424
Inseego
INSG
$78.7M
| $3.46M | 0.01% |
145,931
-13,219
| -8% | -$330K |
|
|
EDGW
1425
DELISTED
Edgewater Technology Inc
EDGW
| $3.46M | 0.01% |
494,400
+26,500
| +6% | +$179K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.